CRISM Therapeutics Corp. engages in the development of cancer treatment drugs for solid tumors. The firm offers ChemoSeed, which is a biodegradable drug delivery technology designed for the delivery of chemotherapy directly into cancer tissue. Its services include formulation and consultancy. The company was founded in March 2016 and is headquartered in Road Town, British Virgin Islands.